News

Stay Updated! In The World Of Investments!
Sensex 49580.73 848.18 (1.74%)

Aurobindo Pharma Latest News

25

Feb, 2021

Aurobindo Pharma informs about transcript of earnings call

With reference to its letter dated February 9, 2021 wherein the company had intimated the schedule of Investors/ Analysts call on February 11, 2021. Aurobindo Pharma has informed that it has enclosed the Transcript ...

Read More

24

Feb, 2021

Aurobindo Pharma trades marginally higher on inking pact to invest in two solar power companies

Aurobindo Pharma is currently trading at Rs. 859.25, up by 3.25 points or 0.38% from its previous closing of Rs. 856.00 on the BSE.

The scrip opened at Rs. 869.00 and has ...

Read More

24

Feb, 2021

Aurobindo Pharma inks pact to invest in two solar power companies

Aurobindo Pharma has entered into binding agreements to invest Rs 5.38 crore each in NVNR (Ramannapet I) Power Plant and NVNR (Ramannapet II) Power Plant, aggregating to Rs 10.76 crore. The company has invested in t...

Read More

19

Feb, 2021

Aurobindo Pharma gets USFDA’s final nod to manufacture, market Droxidopa Capsules

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Droxidopa Capsules, 100 mg, 200 mg and 300 mg. Droxidopa Capsules are generic version of ...

Read More

15

Feb, 2021

Aurobindo Pharma rises despite its unit recalling 3,094 cartons of Acetaminophen injection

Aurobindo Pharma is currently trading at Rs. 932.80, up by 2.90 points or 0.31% from its previous closing of Rs. 929.90 on the BSE.

The scrip opened at Rs. 938.00 and has ...

Read More

15

Feb, 2021

Aurobindo Pharma’s unit recalling 3,094 cartons of Acetaminophen injection

AuroMedics Pharma LLC, a unit of Hyderabad-based Aurobindo Pharma, is recalling 3,094 cartons of Acetaminophen injection. The drug is used to relieve mild to moderate pain and reduce fever.

Read More

09

Feb, 2021

Aurobindo Pharma informs about analyst meet

Aurobindo Pharma has informed that an analyst/ investor call on the Unaudited Financial Results of the Company for the third quarter and nine months period ended 31st December 2020 is scheduled on 11th February 20...

Read More

25

Jan, 2021

Aurobindo Pharma jumps on getting nod for promotion of manufacturing critical bulk drugs

Aurobindo Pharma is currently trading at Rs. 956.00, up by 32.35 points or 3.50% from its previous closing of Rs. 923.65 on the BSE.

The scrip opened at Rs. 930.00 and has...

Read More

23

Jan, 2021

Aurobindo Pharma gets nod for promotion of manufacturing critical bulk drugs

The government has given approval to Aurobindo Pharma under the PLI scheme for promotion of domestic manufacturing of critical bulk drugs. The Production Linked Incentive (PLI) scheme aims at promotion of manufacturing of criti...

Read More

24

Dec, 2020

Aurobindo Pharma gains on entering into exclusive license agreement with COVAXX

Aurobindo Pharma is currently trading at Rs. 897.95, up by 8.05 points or 0.90% from its previous closing of Rs. 889.90 on the BSE.

The scrip opened at Rs. 900.00 and has ...

Read More

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback